Updated: January 4, 2026
Tetracycline Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
- Is Tetracycline in an Active Shortage in 2026?
- What Caused the Tetracycline Shortage?
- Why Is Tetracycline Still Hard to Find Even Without an Active Shortage?
- What Are the Most Affected Patient Groups?
- What Should You Do If You Can't Find Tetracycline?
- How to Monitor Tetracycline Shortage Status Going Forward
- The Bottom Line for 2026
Tetracycline has a complicated shortage history. Here's the latest 2026 update on availability, what caused past shortages, and what patients should do right now.
If you've been prescribed Tetracycline and found it hard to locate at your pharmacy, you're experiencing the tail end of a supply problem that has affected this antibiotic for years. Here's the full picture on the Tetracycline shortage — what happened, where things stand in 2026, and what you can do about it.
Is Tetracycline in an Active Shortage in 2026?
As of 2026, Tetracycline is not on the FDA's active Drug Shortages list as a new shortage. However, the drug continues to be difficult to find at many retail pharmacies due to structural supply chain issues that haven't fully resolved. Generic tetracycline hydrochloride is manufactured in the U.S. market primarily by Amneal Pharmaceuticals — meaning there is limited redundancy if any supply disruption occurs.
In practical terms: the drug exists in the supply chain, but not every pharmacy stocks it, and patients may need to check multiple locations or use a service to find it.
What Caused the Tetracycline Shortage?
Tetracycline experienced a significant multi-year shortage caused by a disruption to the supply of its active pharmaceutical ingredient (API). When a key ingredient supplier stopped production, at least one major manufacturer had to halt production entirely.
Heritage Pharmaceuticals was the first company to come back to the market after the two-year shortage, and the FDA updated its status in November of that year. But even after one manufacturer returned, the drug remained on the FDA's shortage list for some time — a sign of how long supply chain recovery can take.
Why Is Tetracycline Still Hard to Find Even Without an Active Shortage?
There are several structural reasons why Tetracycline remains harder to find than antibiotics like amoxicillin or azithromycin:
- Few manufacturers. When only one or two generics are available on the market, supply disruptions have outsized effects on availability nationwide.
- Low prescribing volume. Doxycycline has largely replaced tetracycline as the go-to tetracycline-class antibiotic. Lower prescribing means pharmacies don't keep consistent stock.
- Low profit margins. Generic antibiotics generate small profits. Fewer companies want to manufacture them, reducing the buffer against supply chain disruptions.
What Are the Most Affected Patient Groups?
Tetracycline availability problems most affect:
- Acne patients on long-term tetracycline therapy who need consistent monthly supply.
- STI patients who need to start treatment quickly (time-sensitive for chlamydia and gonorrhea).
- H. pylori patients prescribed bismuth quadruple therapy, in which tetracycline is a core component.
- Patients with penicillin allergies for whom tetracycline-class antibiotics are one of the primary alternatives.
What Should You Do If You Can't Find Tetracycline?
Here are the steps to take right now:
- Use medfinder to search pharmacies near you that have Tetracycline in stock. medfinder calls pharmacies on your behalf and texts you the results — eliminating hours of phone calls.
- Call your pharmacy and ask if they can order it. Most pharmacies can get a special order from their wholesaler within 1–2 business days.
- Ask your doctor about switching to doxycycline. For most conditions (acne, chlamydia, Lyme disease), doxycycline is an appropriate, widely available substitute.
- Check independent pharmacies. They sometimes stock less-common medications more reliably than chain pharmacies.
How to Monitor Tetracycline Shortage Status Going Forward
Two official sources track drug shortage status in the United States:
- FDA Drug Shortages Database (accessdata.fda.gov/scripts/drugshortages): Lists current and resolved shortages reported by manufacturers. Search for "tetracycline" to see current status.
- ASHP Drug Shortages (ashp.org/drug-shortages): The American Society of Health-System Pharmacists maintains a parallel tracking list with additional details.
The Bottom Line for 2026
Tetracycline is available in 2026, but its limited manufacturing base means it's not consistently stocked everywhere. Patients need to be proactive — check availability before going to the pharmacy, be prepared to call multiple locations, and have a conversation with your doctor about alternatives if needed. For a detailed breakdown of alternatives, see our guide: Alternatives to Tetracycline If You Can't Fill Your Prescription.
Frequently Asked Questions
Tetracycline is not currently on the FDA's active drug shortage list as a new shortage in 2026. However, it remains difficult to find consistently because it is manufactured by a limited number of generic makers and is prescribed less frequently than doxycycline, so not all pharmacies stock it routinely.
The tetracycline shortage was caused by a discontinuance of an active pharmaceutical ingredient, which forced manufacturers to halt production. Heritage Pharmaceuticals was the first manufacturer back on the market after a two-year shortage. Low profit margins and reduced demand relative to doxycycline mean few manufacturers maintain production.
The major tetracycline shortage lasted approximately two years before Heritage Pharmaceuticals resumed production. The FDA kept tetracycline on its shortage list even after Heritage returned, reflecting the slow pace of full supply chain recovery.
First, use medfinder to check other pharmacies near you. You can also ask your current pharmacy to special-order it (typically 1–2 business days). If you need the antibiotic immediately, call your prescriber about switching to doxycycline, which is the most widely available tetracycline-class alternative.
Supply has stabilized from the worst point of the shortage, with Amneal Pharmaceuticals currently manufacturing tetracycline for the U.S. market. However, with a limited manufacturing base, the drug remains vulnerable to periodic spot shortages. Monitoring the FDA drug shortages database is the best way to track current status.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Tetracycline also looked for:
More about Tetracycline
35,181 have already found their meds with Medfinder.
Start your search today.





